Heparin Drip Management When PTT Results Are Unobtainable

Rationale for Continuing Heparin

The American Heart Association recommends continuing the heparin infusion without interruption to avoid subtherapeutic anticoagulation, which increases thrombotic risk 15-fold, as stopping heparin for 2 hours to obtain a PTT result would create an unacceptable period of subtherapeutic anticoagulation 1, 2
Subtherapeutic anticoagulation carries severe consequences: patients with low anticoagulation levels have a 15-fold increased risk of recurrent venous thromboembolism compared to those in therapeutic range 1, 2
Heparin's pharmacokinetics do not support a 2-hour hold, as therapeutic doses are cleared through both rapid saturable mechanisms and slower renal clearance, meaning a 2-hour interruption would result in subtherapeutic levels without providing meaningful diagnostic clarity 1

The American College of Cardiology suggests contacting the laboratory immediately to identify why PTT results cannot be obtained, with common causes including specimen clotting, insufficient sample volume, contamination with heparin, and reagent-specific issues with the aPTT assay 1, 3, 4
Proper specimen collection technique is essential, with blood drawn from a site remote from the heparin infusion and adequate discard volume if drawn from a central line 1

If PTT results remain unobtainable after troubleshooting, the American Heart Association recommends continuing the current heparin infusion rate if the patient was recently started on a weight-based protocol 2, 6
Switching to anti-factor Xa monitoring with a target range of 0.35-0.7 U/mL is recommended if aPTT testing is problematic, particularly in critically ill patients 2, 5, 6

The American College of Cardiology advises never holding therapeutic anticoagulation to obtain a laboratory value when the underlying thrombotic condition remains active, as the risk of recurrent thromboembolism far exceeds the risk of continuing empiric dosing for a brief period 1, 2
It is crucial not to assume the heparin is "working" without objective measurement, and to obtain some form of anticoagulation monitoring within 6 hours of the bolus dose 1, 2

If aPTT continues to be problematic, transitioning to anti-factor Xa monitoring as the primary method is recommended, particularly in critically ill patients where elevated factor VIII and fibrinogen can cause heparin resistance and aPTT unreliability 5
Considering low molecular weight heparin (LMWH) as an alternative is also suggested, if the clinical situation allows, as it requires no routine monitoring and has more predictable pharmacokinetics 2